TerrAscend (TSNDF) Cash from Investing Activities (2021 - 2026)

TerrAscend's (TSNDF) quarterly Cash from Investing Activities came in at $4000.0 in Q1 2026, up 100.14% year-on-year from $1998.6 in Q1 2025, and up 100.35% on a QoQ basis from -$1.1 million in Q4 2025.

TerrAscend (TSNDF) Cash from Investing Activities (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Cash from Investing Activities data on file, last reported at $4000.0 in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 100.14% year-over-year to $4000.0 in Q1 2026; TTM through Mar 2026 was -$11.6 million, a 1.13% increase from a year earlier, with the FY2025 full-year figure at -$14.6 million, down 19.27% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $4000.0, up from -$1.1 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for TSNDF reached as high as $13.9 million in Q1 2022 and fell as low as -$22.7 million in Q3 2023.
  • Historically, Cash from Investing Activities has averaged -$4.8 million across 5 years, with a median of -$3.1 million in 2025.
  • Across the five-year window, Cash from Investing Activities jumped 207.98% in 2022 and tumbled 605.09% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$15.0 million in 2022, then surged by 108.25% to $1.2 million in 2023, then tumbled by 605.09% to -$6.2 million in 2024, then soared by 81.71% to -$1.1 million in 2025, then soared by 100.35% to $4000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $4000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$3.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 TerrAscend 164.05 Mn 163.57 Mn 34.60 Mn 4,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 4,000.00
Mar 31, 2026 4,000.00
Dec 31, 2025 -1.14 Mn
Dec 31, 2025 -1.14 Mn
Sep 30, 2025 -3.08 Mn
Sep 30, 2025 -3.08 Mn
Jun 30, 2025 -7.43 Mn
Jun 30, 2025 -7.43 Mn
Mar 31, 2025 -2.96 Mn
Mar 31, 2025 -2.96 Mn
Dec 31, 2024 -6.25 Mn
Dec 31, 2024 -6.25 Mn
Sep 30, 2024 -956,000.00
Sep 30, 2024 -956,000.00
Jun 30, 2024 -1.62 Mn
Jun 30, 2024 -1.62 Mn
Mar 31, 2024 -3.42 Mn
Mar 31, 2024 -3.42 Mn
Dec 31, 2023 1.24 Mn
Dec 31, 2023 1.24 Mn